Two Sigma Advisers’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.6M | Buy |
|
|||||
|
2025
Q1 | $14.1M | Sell |
|
|||||
|
2024
Q4 | $23.3M | Buy |
|
|||||
|
2024
Q3 | $21.1M | Buy |
|
|||||
|
2024
Q2 | $17.2M | Buy |
|
|||||
|
2024
Q1 | $18.1M | Buy |
|
|||||
|
2023
Q4 | $14.1M | Buy |
|
|||||
|
2023
Q3 | $8.02M | Sell |
|
|||||
|
2023
Q2 | $11.3M | Sell |
|
|||||
|
2023
Q1 | $20M | Sell |
|
|||||
|
2022
Q4 | $20.3M | Sell |
|
|||||
|
2022
Q3 | $32.7M | Sell |
|
|||||
|
2022
Q2 | $37M | Buy |
|
|||||
|
2022
Q1 | $31.8M | Buy |
|
|||||
|
2021
Q4 | $32M | Buy |
|
|||||
|
2021
Q3 | $22.8M | Sell |
|
|||||
|
2021
Q2 | $66.4M | Sell |
|
|||||
|
2021
Q1 | $54.6M | Buy |
|
|||||
|
2020
Q4 | $29.4M | Buy |
|
|||||
|
2020
Q3 | $9.08M | Buy |
|
|||||
|
2020
Q2 | $6.92M | Buy |
|
|||||
|
2020
Q1 | $3.14M | Buy |
|
|||||
|
2019
Q4 | $3.4M | Buy |
|
|||||
|
2019
Q3 | $1.85M | Buy |
|
|||||
|
2019
Q2 | $1.6M | Buy |
|
|||||
|
2019
Q1 | $607K | Buy |
|
|||||
|
2018
Q4 | $288K | Buy |
|